Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Ovarian Neoplasms 11Prostatic Neoplasms 7Fallopian Tube Neoplasms 5Neoplasms 3Breast Neoplasms 3Prostatic Neoplasms, Castration-Resistant 2Neoplasm Metastasis 2Glioblastoma 2Carcinoma, Ovarian Epithelial 2Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Prostate Adenocarcinoma 1Pathologic Complete Response 1Pancreatic Neoplasms 1Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1Metastatic Castration-sensitive Prostate Cancer 1Lung Neoplasms 1Hemangiosarcoma 1Head and Neck Neoplasms 1Glioma 1Endometrial Neoplasms 1Disease Progression 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1Brain Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Temozolomide 37Magnetic Resonance Spectroscopy 21Radiotherapy 18Specimen Handling 15Radiation 10Lomustine 9Bevacizumab 8pembrolizumab 7fludarabine 5Cyclophosphamide 5Surgical Procedures, Operative 4Nivolumab 4Ipilimumab 4Biopsy 4olaparib 3atezolizumab 3Immunoglobulin G 3Disulfides 3Carboplatin 3veliparib 2trametinib 2rocakinogene sifuplasmid 2ribociclib 2poly ICLC 2pamiparib 2niraparib 2lutetium Lu 177 dotatate 2gallium maltolate 2durvalumab 2dabrafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Glioblastoma × niraparib × 90 days × Clear all
NCT06388733 2026-04-01

A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

NeuroTrials, LLC

Phase 3 Recruiting
450 enrolled
CNS

Brain Neoplasms, Glioblastoma

NCT05076513 2026-03-09

Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma

St. Joseph's Hospital and Medical Center, Phoenix

Phase EARLY_PHASE1 Active not recruiting
42 enrolled
CNS

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡